Stay updated on Inhaled GB002 for PAH: Phase III Clinical Trial
Sign up to get notified when there's something new on the Inhaled GB002 for PAH: Phase III Clinical Trial page.

Latest updates to the Inhaled GB002 for PAH: Phase III Clinical Trial page
- Check6 days agoChange DetectedThe sponsor subsidiary name is updated from Gossamer Bio Inc. to Gossamer Bio USA, Inc., and the revision/version is updated from v3.6.3 to v3.6.4.SummaryDifference0.2%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedA new revision, v3.6.3, appears in the record history, indicating an updated version of the page. The previous revision, v3.6.2, is no longer the latest entry in the history.SummaryDifference0.1%

- Check34 days agoChange DetectedA new latest revision v3.6.2 is added to the record history and the older revision v3.6.0 is removed, reflecting an update to the study record's version history.SummaryDifference0.1%

- Check48 days agoChange DetectedThe recruitment status was updated to no longer looking for participants, indicating the study is not seeking new participants. The history also notes a new revision (v3.6.0) and the deletion of the prior revision (v3.5.5).SummaryDifference0.3%

- Check55 days agoChange DetectedThe page history now shows Revision: v3.5.5, replacing the previous v3.5.4. This indicates a minor update to the study record history metadata rather than changes to the study details.SummaryDifference0.1%

- Check77 days agoChange DetectedA new revision entry v3.5.4 was added to the study record history, superseding the previous v3.5.3; it represents an administrative update to the revision history rather than substantive page changes.SummaryDifference0.1%

Stay in the know with updates to Inhaled GB002 for PAH: Phase III Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Inhaled GB002 for PAH: Phase III Clinical Trial page.